FACT-Colorectal: Functional Assessment of Cancer Therapy—Colorectal
Functional Assessment of Cancer Therapy—Colorectal · Also known as: FACT-C
The FACT-Colorectal (FACT-C) is a disease-specific quality-of-life instrument designed for patients with colorectal cancer. It combines the 27-item FACT-G core (general cancer) with a 9-item colorectal-specific subscale addressing bowel function, sexual function, and cancer-related digestive concerns. Validated by Ward et al. in 1999, it is a standard endpoint in colorectal cancer clinical trials and clinical practice monitoring.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
FACT-Colorectal is indicated for patients with colorectal cancer (colon, rectal, appendiceal) at any stage, undergoing surgery, chemotherapy, radiation, or surveillance. Primary use is clinical trials assessing treatment efficacy and patient-reported outcomes; secondary use in oncology clinic monitoring (baseline, q3–6 months during active treatment, post-treatment follow-up). NOT designed for screening or diagnosis. Especially valuable when treatment decisions involve bowel/sexual function trade-offs (e.g., low anterior resection vs. abdominoperineal resection; adjuvant chemo toxicity vs. recurrence prevention).
Strengths & limitations
- Colorectal-specific subscale directly measures bowel function, continence, and sexual concerns—critical QoL domains unique to colorectal cancer and its treatments.
- Validated in large, diverse colorectal cancer populations (stages I–IV, various surgeries and chemotherapy regimens); robust psychometric properties.
- Public domain, no licensing cost; freely available in multiple languages and modalities.
- Extensive use in major cooperative group trials (SWOG, ECOG, EORTC, NCCTG); high regulatory credibility for FDA submissions and pragmatic trials.
- Captures both common cancer burden (via FACT-G) and disease-specific concerns (via CCS); enables comparative analysis of generic vs. specific impact.
- CCS subscale (9 items) may lack granularity for detailed assessment of specific bowel dysfunctions (e.g., distinguishing urgency from incontinence).
- FACT-G core assumes general cancer relevance; some items may be less salient for early-stage post-surgical patients in remission.
- No direct measure of stoma-related concerns (for patients with colostomy/ileostomy); supplementary stoma-specific scales may be needed.
- Ceiling effects in early-stage, post-surgical populations; may not detect subtle QoL improvements.
Frequently asked
Is FACT-C appropriate for patients with a colostomy or ileostomy?
Yes. FACT-C is validated in colorectal cancer patients regardless of surgical approach (sphincter-preserving, low anterior resection, abdominoperineal resection with ostomy). The CCS subscale measures bowel function and adjustment; ostomy patients may have different baseline CCS scores than non-ostomy patients, but the instrument is appropriate for both. Some studies have developed ostomy-specific addenda; consult trial protocol for guidance.
How does FACT-C compare to EORTC QLQ-CR29?
FACT-C (36 items: 27 FACT-G + 9 CCS) has a broader general cancer core plus moderate colorectal-specific detail. EORTC QLQ-CR29 (29 colorectal-specific items added to QLQ-C30 core) emphasizes detailed symptom and functional scales (micturition, defecation, bowel/abdominal symptoms). FACT-C is more prevalent in North America; EORTC more common in Europe. Both are valid; EORTC may better distinguish specific bowel dysfunctions.
What is the MCID for FACT-C, and how is it used clinically?
MCID for FACT-C total is approximately 8–10 points; for CCS subscale, approximately 3–4 points. These thresholds represent the smallest difference a patient would notice as clinically meaningful. In trials, MCID is used to help interpret statistical significance and determine clinical meaningfulness of treatment effects. In clinic, serial FACT-C changes tracked longitudinally are more informative than absolute scores for assessing treatment response and QoL trajectory.
Can FACT-C be used in recurrent or metastatic colorectal cancer?
Yes. FACT-C is validated across all colorectal cancer stages (I–IV). Metastatic patients may have lower baseline and follow-up scores reflecting higher disease and treatment burden. Interpretation should account for disease stage and prognosis; QoL expectations and MCID application differ between curative-intent and palliative-intent settings. Consider combining FACT-C with palliative-specific instruments (e.g., EORTC QLQ-C15-PAL) in advanced disease.
How are missing data handled in FACT-C scoring?
If ≥50% of subscale items are missing, do not score that subscale. If <50% are missing, impute the completed items' mean and multiply by the full subscale item count. For example, if 6 of 7 PWB items are answered, average the 6 and multiply by 7. Always report the number of missing items when presenting FACT-C results; avoid interpretation if data quality is poor (e.g., >2 missing on any subscale).
Is FACT-C a free, public-domain instrument?
Yes. FACT-C is freely available (public domain) with no licensing fees. Copies are available via FACIT.org (www.facit.org) and directly from the developers. Validated translations in 30+ languages are also free or low-cost. Use official versions to ensure psychometric integrity; ad hoc translations or modified versions may not be valid.
Sources
- Ward, W. L., Hahn, E. A., Mo, F., Hernandez, L., Tulsky, D. S., & Cella, D. (1999). Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res, 8(3), 181–195. DOI: 10.1023/a:1008821826499 ↗
- Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol, 11(3), 570–579. DOI: 10.1200/JCO.1993.11.3.570 ↗
How to cite this page
ScholarGate. (2026, June 3). Functional Assessment of Cancer Therapy—Colorectal. ScholarGate. https://scholargate.app/en/oncology/fact-colorectal
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Cancer Worry ScaleOncology↔ compare
- EORTC QLQ-C15-PALOncology↔ compare
- FACT-LungOncology↔ compare
- FACT-OvarianOncology↔ compare
- FACT-ProstateOncology↔ compare